Cost‐effectiveness · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure: number of women with self‐reported continence · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement: number of women with self‐reported improvement in SUI (cured or improved) · women with stress urinary incontinence
Low intensity ES plus PFMT may leads to lower improvement: number of women with self‐reported improvement in SUI… compared with maximal intensity ES plus PFMT (low certainty).
1 finding from 1 review
Incontinence‐specific quality of life · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects ‐ not reported · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness ‐ not reported · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cure: number of women with self‐reported continence · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Improvement: number of women with self‐reported improvement in SUI (cured or improved) (perception of bother of UI symptoms) · women with stress urinary incontinence
1 finding from 1 review
Incontinence‐specific quality of life · women with stress urinary incontinence
1 finding from 1 review
Adverse effects ‐ not reported · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cost‐effectiveness ‐ not reported · women with stress urinary incontinence
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of wet nights per week at the end of treatment ‐ imipramine + oxybutynin vs imipramine · children with nocturnal enuresis
1 finding from 1 review
Intervention not reported
Number of wet nights per week at the end of treatment ‐ Amitriptyline + desmopressin vs amitriptyline · children with nocturnal enuresis
1 finding from 1 review
Intervention not reported
Number not achieving 14 consecutive dry nights at the end of treatment ‐ imipramine + oxybutynin vs placebo · children with nocturnal enuresis
The intervention probably leads to lower number not achieving 14 consecutive dry nights at the end of… (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events assessed as reported in paper · children with nocturnal enuresis
1 finding from 1 review
Overall mortality · critically ill participants with ALI and ARDS
INO showed no clear difference in overall mortality compared with control group (moderate certainty).
1 finding from 1 review
Overall mortality at 28 days · critically ill participants with ALI and ARDS
INO showed no clear difference in overall mortality at 28 days compared with control group (moderate certainty).
1 finding from 1 review
Respiratory effects: PaO2/FiO2 ratio up to 24 hours after initiation of therapy · critically ill participants with ALI and ARDS
INO probably leads to higher paO2/FiO2 up to 24 hours compared with control group (moderate certainty).
1 finding from 1 review
Oxygenation index (absolute values) after 24 hours of treatment · critically ill participants with ALI and ARDS
INO showed no clear difference in oxygenation index, 24 hours compared with control group (moderate certainty).
1 finding from 1 review
Ventilator‐free days up to day 28 · critically ill participants with ALI and ARDS
INO showed no clear difference in ventilation‐free days, up to 30 days compared with control group (high certainty).
1 finding from 1 review